(Q33573907)

28 July 2017

1 reference

title

Key issues in the treatment of advanced breast cancer. Expectations and outcomes (English)

1 reference

28 July 2017

Rubens RD

1

1 reference

28 July 2017

1 January 1996

1 reference

28 July 2017

1 reference

28 July 2017

9 Suppl 2

1 reference

28 July 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199600092-00003

28 July 2017

0 references

cites work

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

12 December 2020

Measurement of quality of life in patients with cancer.

1 reference

12 December 2020

Advanced breast cancer: use of resources and cost implications

1 reference

12 December 2020

A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Appropriate chemotherapy for palliating advanced cancer

1 reference

12 December 2020

The clinical course of bone metastases from breast cancer

1 reference

12 December 2020

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

1 reference

12 December 2020

Taxol (paclitaxel) in patients with metastatic breast carcinoma who have failed prior chemotherapy: interim results of a multinational study

1 reference

12 December 2020

Duration of complete response to chemotherapy in advanced breast cancer

1 reference

12 December 2020

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

1 reference

12 December 2020

Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer

1 reference

12 December 2020

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Chemotherapy of advanced breast cancer: outcome and prognostic factors

1 reference

12 December 2020

10.2165/00019053-199600092-00003

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10163964